4.8 Article

High Sensitivity Extended Nano-Coulter Counter for Detection of Viral Particles and Extracellular Vesicles

期刊

ANALYTICAL CHEMISTRY
卷 95, 期 26, 页码 9892-9900

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acs.analchem.3c00855

关键词

-

向作者/读者索取更多资源

We have developed a chip-based extended nano-Coulter counter (XnCC) capable of detecting nanoparticles affinity-selected from biological samples with an extremely low concentration limit-of-detection. The XnCC contains 5 in-plane pores and can efficiently detect single particles translocating through these pores. The XnCC has been successfully utilized for counting affinity-selected SARS-CoV-2 viral particles and ovarian cancer extracellular vesicles, demonstrating its potential in clinical applications.
We present a chip-based extended nano-Coulter counter(XnCC) thatcan detect nanoparticles affinity-selected from biological sampleswith low concentration limit-of-detection that surpasses existingresistive pulse sensors by 2-3 orders of magnitude. The XnCCwas engineered to contain 5 in-plane pores each with an effectivediameter of 350 nm placed in parallel and can provide high detectionefficiency for single particles translocating both hydrodynamicallyand electrokinetically through these pores. The XnCC was fabricatedin cyclic olefin polymer (COP) via nanoinjection molding to allowfor high-scale production. The concentration limit-of-detection ofthe XnCC was 5.5 x 10(3) particles/mL, which was a 1,100-foldimprovement compared to a single in-plane pore device. The applicationexamples of the XnCC included counting affinity selected SARS-CoV-2viral particles from saliva samples using an aptamer and pillaredmicrochip; the selection/XnCC assay could distinguish the COVID-19(+)saliva samples from those that were COVID-19(-). In the secondexample, ovarian cancer extracellular vesicles (EVs) were affinityselected using a pillared chip modified with a MUC16 monoclonal antibody.The affinity selection chip coupled with the XnCC was successful indiscriminating between patients with high grade serous ovarian cancerand healthy donors using blood plasma as the input sample.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据